We used the Apo2L/TRAIL-sensitive lung carcinoma cell line H460 and the Apo2L/TRAIL-resistant colon carcinoma cell line HCT116 Bax-/- as positive and negative controls, respectively [19,20]. The gene discussed is TNFSF10; the disease is colon carcinoma.